Lord Abbett Health Care R5 (LHCTX)

Fund Assets	8.74M
Expense Ratio	0.814%
Min. Investment	$0.00
Turnover	91.00%
Dividend (ttm)	0.08
Dividend Yield	0.36%
Dividend Growth	-23.07%
Payout Frequency	Annual
Ex-Dividend Date	Dec 2, 2025

Previous Close	24.01
YTD Return	5.59%
1-Year Return	15.47%
5-Year Return	24.36%
52-Week Low	20.67
52-Week High	25.30
Beta (5Y)	n/a
Holdings	55
Inception Date	Jul 31, 2019

About LHCTX

Lord Abbett Health Care Fund Class R5 is an actively managed mutual fund that focuses on delivering long-term capital growth by investing primarily in equity securities of companies within the health care sector. The fund’s portfolio is diversified across areas such as pharmaceuticals, biotechnology, medical devices, and health care services. Managed by Lord Abbett’s experienced investment team, the fund seeks to capitalize on innovation, demographic changes, and advancements within global health care industries. A distinguishing feature of this fund is its commitment to specialization: approximately 96% of its assets are allocated to health care holdings, with a small balance in repurchase agreements. The fund typically holds around 61 securities, providing both sector concentration and diversified exposure within health care. Designed for institutional investors, the Class R5 share class is structured with a lower net expense ratio relative to other share classes, potentially enhancing cost efficiency for larger organizations. With significant assets under management and a portfolio turnover rate that reflects an active approach, the Lord Abbett Health Care Fund Class R5 plays a critical role for investors seeking targeted participation in health care industry growth, making it a relevant vehicle in sector-based investment strategies.

• Fund Family: Lord Abbett
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: LHCTX
• Share Class: Class R5
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCTX had a total return of 15.47% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.82%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCVX	Class R6	0.68%
LHCIX	Class I	0.78%
LHCFX	Class F	0.78%

Top 10 Holdings

44.28% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.72%
UnitedHealth Group Incorporated	UNH	5.57%
Johnson & Johnson	JNJ	5.11%
Novartis AG	NOVN	4.32%
Natera, Inc.	NTRA	3.71%
Gilead Sciences, Inc.	GILD	3.64%
CVS Health Corporation	CVS	3.44%
Guardant Health, Inc.	GH	2.69%
Galderma Group AG	GALD	2.68%
Thermo Fisher Scientific Inc.	TMO	2.39%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 2, 2025	$0.0847	Dec 2, 2025
Nov 26, 2024	$0.1101	Nov 26, 2024
Nov 22, 2022	$0.0233	Nov 22, 2022
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3182	Nov 24, 2020
Nov 21, 2019	$0.0069	Nov 21, 2019

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 17, 2026

Data Sources Report a data error